第21回あわじ感染と免疫国際フォーラム

セッション情報

ポスター

[P1] Poster Discussion 1 (Odd Numbers)

2023年9月4日(月) 14:10 〜 15:10 講演会場 (メインバンケットホール長野)

Yuki Akari1, Riona Hatazawa1, Manami Negoro2, Takaaki Tanaka3, Kazutoyo Asada4, Haruna Miwa4, Katsumi Sugiura4,5, Masakazu Umemoto6, Haruo Kuroki7, Hiroaki Ito8, Shigeki Tanaka9, Mitsue Ito10, Saori Fukuda1, Takayuki Murata1, Kiyosu Taniguchi4, Shigeru Suga4, Hajime Kamiya11, Takashi Nakano4, Koki Taniguchi1, Satoshi Komoto1,12 (1.Department of Virology, Fujita Health University School of Medicine, Aichi, Japan, 2.Institute for Clinical Research, National Mie Hospital, Mie, Japan, 3.Department of Pediatrics, Kawasaki Medical School, Okayama, Japan, 4.Department of Pediatrics, National Mie Hospital, Mie, Japan, 5.Department of Pediatrics, Matsusaka Chuo General Hospital, Mie, Japan, 6.Umemoto Children's Clinic, Mie, Japan, 7.Child and Adult Clinic, Tokyo, Japan, 8.Department of Pediatrics, Kameda Medical Center, Chiba, Japan, 9.Department of Pediatrics, Mie Chuo Medical Center, Mie Japan, 10.Department of Pediatrics, Japanese Red Cross Ise Hospital, Mie, Japan, 11.Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan, 12.Research Center for GLOBAL and LOCAL Infectious Disease, Oita University, Oita, Japan)

Jalal Alshaweesh1, Ranadhir Dey2, Telly Sepahpour2, Kamaleshwar Singh3, Patrick Lypaczewski4, Subir Karmakar3, Swarnendu Kaviraj3, Sanjay Singh3, Nazli Azodi2, Sreenivas Gannavaram2, Abhay Satoskar5, Greg Matlashewski4, Hira Nakhasi2, Shinjiro Hamano1 (1.Institute of Tropical Medicine, Nagasaki University, Japan, 2.Division of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Silver Spring, USA, 3.Gennova Biopharmaceuticals, Hinjawadi Phase II, Pune, Maharashtra, India, 4.Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada, 5.Department of Pathology and Microbiology, Ohio State University, Columbus, OH, USA)

Yuka Appelboom1,2,3, Huai Chuang2,3, Yuko Katakai4, Satoru Kawai5, Miako Sakaguchi6, Osamu Kaneko2,3 (1.Master's program of Biomedical Sciences, Leiden University Medical Center, Leiden University, Netherland, 2.Department of Protozoology, Institute of Tropical Medicine, Nagasaki University, Japan, 3.Graduate School of Biomedical Sciences, Nagasaki University, Japan, 4.The Corporation for Production and Research of Laboratory Primates, Japan, 5.Department of Tropical Medicine and Parasitology, Dokkyo Medical University, Japan, 6.Central Laboratory, Institute of Tropical Medicine, Nagasaki University, Japan)

Shyam Prakash Dunre1, Sabin Shrestha1, Dhiraj Acharya2, Prakash Ghimire1, Takamatsu Yuki3, Basu D Pandey4, Kouichi Morita3,4,5, Mya Myat Ngwe Tun3,4,5 (1.Central Department of Microbiology, Tribhuvan University, 2.Cleveland Clinic, Florida Research and Innovation Center, Florida, USA, 3.Department f Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan, 4.DEJIMA Infectious Disease Research Alliance, Nagasaki University, Nagasaki , Japan, 5.Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan)

Chukwuma S Ezenwanne1,2, Huai Chuang2,3, Taeko Naruse2,3, Yuko Katakai4, Satoru Kawai5, Bruce Russell2,6, Miako Sakaguchi7, Osamu Kaneko2,3 (1.School of Tropical Medicine and Global Health, Nagasaki University, Japan, 2.Department of Protozoology, Institute of Tropical Medicine, Nagasaki University, Japan, 3.Graduate School of Biomedical Sciences, Nagasaki University, Japan, 4.The Corporation for Production and Research of Laboratory Primates, Japan, 5.Deptartment of Tropical Medicine and Parasitology, Dokkyo Medical University, Japan, 6.Department of Microbiology and Immunology, University of Otago, New Zealand, 7.Central Laboratory, Institute of Tropical Medicine, Nagasaki University, Japan)

Zhihan Guo1, Masato Murakami1,2, Kaori (Otsuka) Saito1,3, Hiroko Kato1, Manami Toriyama1,4,5, Makoto Tominaga6,7,8, Ken J Ishii4,9, Fumitaka Fujita1,3 (1.Grad. Sch. of Pharm., Osaka Univ., 2.Skin Care Inst. Mandom Corp., 3.Adv. Tech. Inst., Mandom Corp., 4.CVAR, NIBIOHN, 5.Grad. Sch. of Sci. Technol., NAIST, 6.ExCELLS, NINS, 7.NIPS, NINS, 8.Dept. of Physiol. Sci., SOKENDAI, 9.Div. of Vaccine Sci., Dept. of Microbio. Immunol., Inst of Med. Sci., Univ. of Tokyo)

Tomoya Hayashi1,2,3, Shuntaro Shimizu1, Koji Sakamoto4, Naozumi Hashimoto5, Kouji Kobiyama1,2,3, Hideo Negishi1,2, Burcu Temizoz1,2,3, Cevayir Coban6, Ken Ishii1,2,3 (1.Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo (IMSUT), Japan, 2.International Vaccine Design Center, IMSUT, Tokyo, Japan, 3.Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research (CVAR), National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan, 4.Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan, 5.Department of Respiratory Medicine, Fujita Health University, Nagoya, Japan, 6.Division of Malaria Immunology, Department of Microbiology and Immunology, IMSUT, Tokyo, Japan)

Minami Nagai1, Moriyama Miyu1, Ishii Chiharu2, Mori Hirotake3, Watanabe Hikaru4, Nakahara Taku4, Yamada Takuji5, Ishikawa Dai3, Ishikawa Takamasa2, Hirayama Akiyoshi2, Kimura Ikuo6, Nagahara Akihito3, Naito Toshio3, Fukuda Shinji2, Ichinohe Takeshi1 (1.Institute of Medical Science, The University of Tokyo,, 2.Institute for Advanced Biosciences, Keio University, 3.Juntendo University Faculty of Medicine, 4.Metagen Therapeutics, Inc., 5.Department of Life Science and Technology, Tokyo Institute of Technology,, 6.Graduate School of Biostudies, Kyoto University)

Dhira S Anggramukti1, Eiji Ishii1,2, Andre Pratana1, Mohamad Al kadi1, Tetsuya Iida1,2, Toshio Kodama3, Shigeaki Matsuda1,2 (1.Research Institute for Microbial Diseases, Osaka University, 2.Center for Infectious Disease Education and Research, Osaka University, 3.Institute of Tropical Medicine, Nagasaki University)

ZECHENG JIN1,2, Shuhei Taguwa1,2,3, Kentaro Uemura1,2, Junki Hirano1,2, Kazuma Okada1,2, Chikako Ono1,2, Taroh Kinoshita1,2, Yusuke Maeda1,2, Yoshiharu Matsuura1,2,3 (1.Research Institute for Microbial Diseases (RIMD), Osaka University, Osaka, Japan, 2.Center for Infectious Disease Education and Research (CiDER), Osaka University, Osaka, Japan, 3.Center for Advanced Modality and DDS (CAMaD), Osaka University, Osaka, Japan)

Mei-Chen TAN1, Ying-Chi HUANG1, Pei-Jing CHEN1, Wei-Cheng HUANG1, Shu-Yuan HSU2, Hui-Ying WANG1, Ci-Hong LIOU1, Jun-Ren SUN3, Tsai-Ling Yang LAUDERDALE1, Shu-Chen KUO1 (1.National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli County, Taiwan, 2.Institute of Population Health Sciences, National Health Research Institutes, Miaoli County, Taiwan, 3.Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan)

Michelle Sue Jann Lee1,2, Camila del Rosario Zorrilla1, Julia Matsuo Dapaah1, Yoshiki Omatsu3, Takashi Nagasawa3, Ken J. Ishii2,4, Cevayir Coban1,2 (1.Division of Malaria Immunology, Institute of Medical Science, The University of Tokyo, 2.International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, 3.Laboratory of Stem Cell Biology and Developmental Immunology, WPI Immunology Frontier Research Center, Osaka University, 4.Division of Vaccine Science, The Institute of Medical Science, The University of Tokyo)

Koki Mayusumi1, Kazuya Kabayama1,2,3, Kazuko Kaneda-Nakashima2,3, Kazuhiro Ooe2,3, Atsushi Toyoshima2,3, Koichi Fukase1,2,3 (1.Department of Chemistry, Graduate School of Science, Osaka University, Japan, 2.FRC, Graduate School of Science, Osaka University, Japan, 3.Institution for Radiation Sciences, Osaka University, Japan)

Masahiro Nakano1,2,3, Ohnishi Chiho1, Muramoto Yukiko1,2,3, Noda Takeshi1,2,3 (1.Laboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Japan, 2.Laboratory of Ultrastructural Virology, Graduate School of Biostudies, Kyoto University, Japan, 3.CREST, Japan Science and Technology Agency, Japan)

Shiori Oka1, Miyuki Watanabe2,3, Emi Ito2,3, Ami Takeyama2,3, Takuro Matsuoka1, Norihito Arichi1, Hiroaki Ohno1, Sho Yamasaki2,3, Shinsuke Inuki1 (1.Graduate School of Pharmaceutical Sciences, Kyoto University, Japan, 2.Research Institute for Microbial Diseases, Osaka University, Japan, 3.Immunology Frontier Research Center (IFReC), Osaka University, Japan)

Chikako Ono1,2, Masanao Sato3, Kentaro Uemura1,2, Junki Hirano1,2, Shuhei Taguwa1,2, Yoshiharu Matsuura1,2 (1.Laboratory of Virus Control, Center for Infectious Disease Education and Research, Osaka University, Osaka, Japan., 2.Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan., 3.Laboratory of Applied Molecular Entomology, Research Faculty of Agriculture, Hokkaido University, Sapporo, Japan)

Arnon Plianchaisuk1, Daichi Yamasoba1,2, Keiya Uriu1, Yusuke Kosugi1, Lin Pan1, Jiri Zahradnik3, Jumpei Ito1, Kei Sato1 (1.Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 2.Faculty of Medicine, Kobe University, Kobe, Japan, 3.First Medical Faculty at Biocev, Charles University, Vestec-Prague, Czechia)

Eita Sasaki1, Hideki Asanuma2, Haruka Momose3, Keiko Furuhata3, Takuo Mizukami3, Takayuki Matsumura1, Isao Hamaguchi3, Yoshimasa Takahashi1 (1.Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan, 2.Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases, Tokyo, Japan, 3.Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases, Tokyo, Japan)

Shuntaro Shimizu1, Tomoya Hayashi1,2,3, Koji Sakamoto4, Naozumi Hashimoto5, Kouji Kobiyama1,2,3, Hideo Negishi1,2, Brucu Temizoz1,2,3, Cevayir Coban2,6, Ken J Ishii1,2,3 (1.Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo (IMSUT), Tokyo, Japan, 2.International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo (IMSUT), Tokyo, Japan, 3.Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research (CVAR), National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan, 4.Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan, 5.Department of Respiratory Medicine, Fujita Health University, Nagoya, Japan, 6.Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo (IMSUT), Tokyo, Japan)

Shirley V Simpson1, Charles Quaye2, Hiroaki Arima1, Paul Mathe Mowa Kambale1, Rita A. Owusu3, Nana Konama Kotey4, Lydia Mosi5, Kingsley Asiedu6, Kennedy Kwasi Addo2, Rie Roselyne Yotsu7, Taro Yamamoto1 (1.Institute of Tropical Medicine, NU, 2.Noguchi Memorial Institute of Medical Research, UG, 3.Aowin Municipality Health Administration, GHS, 4.National Buruli ulcer Control & Yaws Eradication Programme, Disease Control & Prevention Department, GHS, 5.Department of Biochemistry, Cell and Molecular Biology, UG, 6.Department of Control of Neglected Tropical Diseases, WHO, 7.School of Public Health and Tropical Medicine, Tulane University, USA)

Shuhei Taguwa1,2,3, Inaba Hikaru1,2, Zecheng Jin1,2, Vicente Bou Prados Juan1,2, Hirano Junki1,2, Uemura Kentaro1,2, Okada Kazuma1,2, Ono Chikako1,2, Yeh Ming-Te3, Gestwicki Jason4, Matsuura Yoshiharu1,2,3 (1.Laboratory of Virus Control, Center for Infectious Disease Education and Research (CiDER), 2.Laboratory of Virus Control, Department of Virology, Research Institute for Microbial Diseases (RIMD), 3.Center for Advanced Modalities and DDS (CAMaD), Osaka University, Japan, 4.Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, USA)

DA TENG3, Keiji Ueda1, Tomoyuki Honda2,3 (1.Division of Virology, Department of Microbiology and Immunology, Osaka University Graduate School of Medicine, 2.Department of Virology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 3.Department of Virology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University)

Edwin Too1,2, Chaiyawong Nattawat1,2, Ishizaki Takahiro1,2, Zin Tun Thant2,3, Baba Minami2,3, Hakimi Hassan2, Asada Masahito1,2, Yahata Kazuhide2,3, Kaneko Osamu1,2 (1.Program for Nurturing Global Leaders in Tropical and Emerging Communicable Diseases, Graduate School of Biomedical Sciences, Nagasaki University, 2.Department of Protozoology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Japan, 3.Department of Infection Research Standard Course, Graduate School of Biomedical Sciences, Nagasaki University, Japan.)

Thant Zin Tun1,2, Nattawat Chaiyawong2,3, Takahiro Ishizaki2,3, Masahito Asada2,3, Kazuhide Yahata1,2, Minami Baba1,2, Osamu Kaneko1,2,3 (1.Standard Course, Graduate School of Biomedical Science, Nagasaki University, Nagasaki, Japan, 2.Department of Protozoology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan, 3.Leading Program, Graduate School of Biomedical Science, Nagasaki University, Nagasaki, Japan)

Fabien Z Vulu1,2,3, Kyoko Futami1, Toshihiko Sunahara1, Pitshou Mampuya3, Thierry L Bobanga3, Dieudonne N Mumba3,4, Minakawa Noboru1 (1.Institute of Tropical Medicine, Nagasaki University, Japan, 2.Graduate School of Biomedical Sciences, Nagasaki University, Japan, 3.Tropical Medicine, Infectious and Parasitic Diseases, University of Kinshasa, DR Congo, 4.Department of Parasitology, National Institute of Biomedical Research, Kinshasa, DR Congo)

Masaya Yamaguchi1,2, Momoko Kobayashi3, Kunio Kawanishi4, Masayuki Ono3, Daisuke Motooka5, Daisuke Okuzaki2,5,6, Shigetada Kawabata2,3 (1.Bioinformatics Research Unit, Osaka University, Graduate School of Dentistry, Japan, 2.Osaka University, Center for Infectious Disease Education and Research, Japan, 3.Department of microbiology, Osaka University, Graduate School of Dentistry, Japan, 4.Faculty of Medicine, University of Tsukuba, Japan, 5.Research Institute for Microbial Diseases, Osaka University, Japan, 6.WPI Immunology Frontier Research Center, Osaka University, Japan)

Yukiko Atsumi1,2, Manami Toriyama1,2,3, Hiroko Kato1,2, Motoki Nakamura1,4, Akimichi Morita4, Masayuki Takaishi1,5,6 ,Kaori Saito1,2,5, Miku Tanaka1,5, Fumihiro Okada5, Makoto Tominaga6,7, Ken J Ishii2,8,9, Fumitaka Fujita1,2,5,6 (1.Grad. Sch. of Pharm. Sci, Osaka Univ, 2.NIBIOHN, 3.NAIST, Div. of Biol. Sci, 4.Grad. Sch. of Med. Sci, Nagoya City Univ, 5.Mandom Corp, 6.ExCELLS, NINS, 7.NiPS, NINS, 8.iFReC, Osaka Univ., 9.The Inst. of Med. Sci, The Univ. of Tokyo)

×

認証

×

要旨・抄録、PDFの閲覧には参加者用アカウントでのログインが必要です。参加者ログイン後に閲覧・ダウンロードできます。
» 参加者用ログイン